Clinical Trials Logo

Clinical Trial Summary

In this study, advanced techniques of myocardial nuclear magnetic perfusion scanning were used to quantitatively assess infarct size after acute myocardial infarction, saved viable myocardium, and microcirculatory obstruction area. Objectively and quantitatively evaluate early use of cardiomyopeptidin for direct PCI of ST-segment elevation myocardial infarction. After the improvement of microcirculation and increase the intervention effect of viable myocardium.


Clinical Trial Description

This is a prospective, randomized, controlled, single-blind, single-center clinical trial. Patients with ST-segment elevation myocardial infarction (STEMI) who were admitted in the People's Liberation Army General Hospital were equally randomized to receive either cardiomyopeptidin or placebo, and patients in cardiomyopeptidin group are given the injection of cardiomyopeptidinl before primary percutaneous coronary intervention (PCI) and intravenous infusion of cardiomyopeptidin was performed 3 days after primary PCI. Myocardial perfusion flow grade was evaluated by the result of primary PCI. Myocardial infarct size, microvascular obstruction and salvage myocardium were evaluated by enhanced cardiac magnetic resonance (CMR). Major adverse cardiovascular events (nonfatal myocardial infarction, all-cause death, hospitalization for acute heart failure, and revascularization for angina) were observed during the 6-month follow-up. CMR is performed to evaluate the effect of cardiomyopeptidin before primary PCI on myocardial salvage and microcirculation perfusion in patients with STEMI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03958422
Study type Interventional
Source Dalian Zhen-Ao Bio-Tech Co., Ltd.
Contact Geng Qian
Phone 13810914587
Email zouzouyuting@163.com
Status Not yet recruiting
Phase Phase 4
Start date June 1, 2019
Completion date January 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT00949715 - Optimize RV Follow-up Selective Site Pacing Clinical Trial N/A
Completed NCT01091467 - Prospective Study of Heart Failure With Preserved Left Ventricular Ejection Fraction
Recruiting NCT05105984 - Evaluation of a Free-breathing Cardiac Cine-MRI Sequence With Image Reconstructions by Deep-Learning in Ischemic Heart Disease
Not yet recruiting NCT00388245 - Revascularization in Heart Failure Trial – REHEAT 2 Phase 4
Recruiting NCT05652218 - REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT) N/A
Completed NCT01786512 - COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure Phase 2
Completed NCT05550792 - Cardiac Contractility Modulation in Patients With Chronic Heart Failure and the Various Forms of Atrial Fibrillation N/A